Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

13.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
13.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peptide Marriages: Modular Assembly of Multi-Agonist Therapeutics.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Multicomponent Stapling of Glucagon-Like Peptide-1 Enables Receptor-Guided PROTAC Delivery.

Angewandte Chemie (International ed. in English)·2026
Same author

Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates.

Chemical science·2026
Same author

On-resin assembly of cysteine-reactive linkers for controlled site-selective antibody bioconjugation.

Nature protocols·2026
Same author

Towards the targeted protein degradation of CK2: design and synthesis of CAM4066-based PROTACs.

Beilstein journal of organic chemistry·2026
Same author

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Breast cancer research : BCR·2026

Related Experiment Video

Updated: Jan 17, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
08:06

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

9.5K

β-Lactamase cleavable antimicrobial peptide-drug conjugates.

Tomas Deingruber1, Josephine S Gaynord1, Bee Ha Gan1

  • 1Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Road Cambridge UK spring@ch.cam.ac.uk.

Chemical Science
|September 22, 2025
PubMed
Summary

New peptide-drug conjugates offer a promising strategy against antimicrobial resistance. These novel therapeutics combine a cleavable linker, an antimicrobial peptide, and a drug to combat resistant bacterial strains effectively.

More Related Videos

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.0K

Related Experiment Videos

Last Updated: Jan 17, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
08:06

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

9.5K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.0K

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Antimicrobial resistance (AMR) poses a significant global health threat, diminishing the efficacy of existing antibacterial treatments.
  • There is an urgent need for novel therapeutic strategies to overcome bacterial resistance mechanisms.
  • Current approaches focus on responsible antibiotic use and the development of new drugs.

Purpose of the Study:

  • To develop and evaluate a novel cleavable peptide-drug conjugate for targeting bacteria with diverse resistance mechanisms.
  • To investigate the components and activity of the conjugate for potential therapeutic applications against resistant bacterial infections.

Main Methods:

  • Design and synthesis of a peptide-drug conjugate comprising a β-lactamase cleavable linker, a stapled antimicrobial peptide, and an antibiotic.
  • Investigation of conjugate activity, including cleavage by β-lactamase and determination of minimal inhibitory concentrations (MICs).
  • Comparison of the cleavable conjugate's potency against a non-cleavable control.

Main Results:

  • The synthesized conjugate demonstrated selective cleavage by β-lactamase.
  • The cleavable peptide-drug conjugate exhibited superior antimicrobial potency compared to its non-cleavable counterpart.
  • Minimal inhibitory concentrations indicated enhanced efficacy against resistant bacterial strains.

Conclusions:

  • Cleavable peptide-drug conjugates represent a viable strategy for combating antimicrobial resistance.
  • The designed conjugate, featuring a cleavable linker and stapled peptide, shows promise for treating infections caused by resistant bacteria.
  • This approach offers a dual mode of action to reduce resistance development and potentially lower systemic toxicity.